Mushroom boardroom: Why some execs are using psychedelics to get through the workday

This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing

‘Still not a top tier ad platform’: Advertisers on Linda Yaccarino’s departure as CEO of X
Linda Yaccarino — the CEO who was never really in charge.

Questions swirl after X CEO Linda Yaccarino departs from the platform
Her departure marks the end of two tumultuous years at the platform.

Creator marketing has the reach — CMOs want the rigor
The creator economy got big enough to be taken seriously.